C. Kyriakopoulos

Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

R. Sebra, M. Galsky, T. Dorff, 2023, Nature Medicine.

Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancer

D. McNeel, L. Johnson, H. Emamekhoo, 2023, Journal for ImmunoTherapy of Cancer.